Star Imaging & Path Lab Ltd. · BSE:STARIMAGIN
Star Imaging & Path Lab — H1 FY27 Earnings Presentation
30 slides from Star Imaging & Path Lab's earnings presentation, Nov 17, 2026
Slide 1: BSE filing letter: presentation for earnings call
Date: 17th November 2026 To, Listing Compliance Department BSE Limited, Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 Scrip Code: 544482 Scrip Symbol: STARIMAGIN Dear Sir / Ma’am, Reg: Disclosure under Regulation 30(6) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation
Slide 2: Star Imaging and Path Lab Limited Investor Presentation H1 FY27
STAR IMAGING AND PATH LAB LIMITED INVESTOR PRESENTATION H1 FY27 Earnings Update 1
Slide 3: Contents
CONTENTS 01 Performance Company Business Model & snapshot Overview Service Portfolio Growth Technology & Financial Strategy Infrastructure Performance Industry Outlook 2
Slide 4: Executive Summary – H1 FY27
EXECUTIVE SUMMARY – H1 FY27 Revenue and profitability Return and capital Operations & Network REVENUE RETURN ON CAPITAL EMPLOYED DIAGNOSTIC CENTERS ₹ 48.9 crores 8% 18.5% 26 YoY growth vs 28.6% in FY26 vs 24 in FY26 EBITDA RETURN ON EQUITY TEAM SIZE ₹ 14.1 crores 14.2% 266 vs ₹17.3 Crs in H1 FY26 vs
Slide 5: Performance Update and Management Commentary – H1 FY27
PERFORMANCE UPDATE AND MANAGEMENT COMMENTARY – H1 FY27 • Growth driven by stronger B2B partnerships, rising B2C activity and improved operational BUSINESS efficiencies across existing centres • Enhanced advanced imaging capabilities through the installation of a high-end 640-slice CT scanner. UPDATE
Slide 6: Multi-Channel Business Model
MULTI - CHANNEL BUSINESS MODEL B2G B2B B2C TOTAL 21% +8% -1% +20% 5.2 18.2 25.8 25.6 15.0 48.9 4.3 45.2 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 REVENUE CONTRIBUTION (%) H1 FY26 H1 FY27 One businesses was classified under B2C 10% 11% B2G in the previously published data; that
Slide 7: Service-wise Revenue Bifurcation
SERVICE - WISE REVENUE BIFURCATION FY26 H1 FY26 H1 FY27 0% 2% 0% 2% 0% 3% 0% 0% 0% 14% 14% 16% 83% 83% 81% Radiology Pathology Neurology Cardiology Urology Industry FY26 H1 FY26 H1 FY27 YoY Change Radiology 73.6 37.4 39.7 6% Pathology 12.3 6.5 7.6 17% Cardiology 2.2 1.1 1.3 22% Neurology 0.4 0.2 0.2
Slide 8: Geographic Diversification: Expanding Regional Footprint
GEOGRAPHIC DIVERSIFICATION: EXPANDING REGIONAL FOOTPRINT DELHI UTTAR PRADESH NASHIK H1 FY27 revenue: ₹24.9 crores H1 FY27 revenue: ₹22.4 crores H1 FY27 revenue: ₹1.7 crores Consistent revenue share above 45% Services offered through royalty-based Strong PPP-based radiology services over FY23-FY26 B2
Slide 9: Contents
CONTENTS Performance 02 Company Business Model & snapshot Overview Service Portfolio Growth Technology & Financial Strategy Infrastructure Performance Industry Outlook 8
Slide 10: Comprehensive Testing Under One Roof
STAR IMAGING AND PATH LAB LIMITED: COMPREHENSIVE TESTING UNDER ONE ROOF Star Imaging and Path Lab Limited is a NABL-accredited diagnostic services provider, offering comprehensive pathology, radiology, cardiology, and neurology services in Delhi, Uttar Pradesh and Maharashtra (Nasik). The Company op
Slide 11: Diverse and Experienced Leadership Team
DIVERSE AND EXPERIENCED LEADERSHIP TEAM MR. PAWAN GUPTA DR. SAMEER SOOD Chairman & Managing Director Non-Executive Director Mr. Pawan Gupta, Chairman and Managing Director of Star Imaging and Dr. Sameer Sood, Non-Executive Director of Star Imaging and Path Lab Path Lab Limited, has run family diagno
Slide 12: Contents
CONTENTS Performance Company 03 Business Model & snapshot Overview Service Portfolio Growth Technology & Financial Strategy Infrastructure Performance Industry Outlook 11
Slide 13: Strategic Moat: Defensible Market Position
STRATEGIC MOAT : DEFENSIBLE MARKET POSITION 01 02 03 04 Scalable hub-and-spoke Long-standing brand with Strong B2G PPP expertise model with digital 50+ years heritage. revenue visibility & government affiliations. integration. 05 06 07 08 Skill Development and Centralized EMR Emerging B2C revenue Tr
Slide 14: Comprehensive Diagnostics: Pathology to Urology
COMPREHENSIVE DIAGNOSTICS: PATHOLOGY TO UROLOGY RADIOLOGY PATHOLOGY CARDIAC NEUROLOGY UROLOGY & SERVICES SERVICES TEST DIAGNOSTICS OTHER TESTS • Digital X-Ray • Hematology • ECG Digital • EEG • PFT • Mammography • Microbiology • Stress TMT • EMG • FibroScan • CT Scans • PCR • Echo • NCV • Uroflowmet
Slide 15: Diagnostic Services: From Routine Testing to Specialized Care
DIAGNOSTIC SERVICES: FROM ROUTINE TESTINGTO SPECIALIZED CARE Company offers one-stop solution of pathology, radiology testing services through itsoperational network RADIOLOGY EQUIPMENT CT-Scan X-Ray MRI Advanced radiology Routine testing Specialized testing services ECG Ultrasound EEG • Involves te
Slide 16: Contents
CONTENTS Performance Company Business Model & snapshot Overview Service Portfolio 04 Growth Technology & Financial Strategy Infrastructure Performance Industry Outlook 15
Slide 17: Growth Blueprint: Key Business Strategies Ahead
GROWTH BLUEPRINT: KEY BUSINESS STRATEGIES AHEAD Accelerating Growth Through Deepening Hospital Scaling Government PPP Operations: Capacity Addition: Partnerships: Three projects are currently in the pipeline for Deploy planned FY27 capital expenditure of ₹20-25 execution, covering CT, MRI, ultrasoun
Slide 18: Contents
CONTENTS Performance Company Business Model & snapshot Overview Service Portfolio Growth 05 Technology & Financial Strategy Infrastructure Performance Industry Outlook 17
Slide 19: Public-Private Partnerships: Delivering Diagnostics at Scale
PUBLIC-PRIVATE PARTNERSHIPS: DELIVERING DIAGNOSTICS AT SCALE Making diagnostic services available to a broader population through government collaborations Collaborating with governments of Uttar Pradesh, Delhi, and Nashik under PPP model for diagnostic services Responsible for establishment, operat
Slide 20: Diagnostics Workflow: Seamless, Accurate and Efficient
RADIOLOGY SERVICES WORKFLOW RADIOLOGY SERVICES WORKFLOW 01 01 SAMPLE COLLECTION AMBULANCE PICKUP 02 02 TRANSPORTATION SCANNING PROCEDURES 03 03 PROCESSING 3D RECONSTRUCTION DIAGNOSTICS WORKFLOW: SEAMLESS, ACCURATE AND EFFICIENT 04 04 REPORT APPROVAL BY PATHOLOGIST REPORT PREPARATION 05 05 EMR INTEGR
Slide 21: Facility Snapshot: Imaging and Path Lab Capabilities
Facility snapshot: Imaging and path lab capabilities 20
Slide 22: Tech-driven Diagnostics: Central Hub and AI-enabled Operations
Tech-driven diagnostics: Central hub and AI-enabled operations Central tele-reporting hub for Leveraging integrated IT systems and AI tools to enhance scalability and quality diagnostic accuracy, efficiency, and scalability EMR integration for real-time access to diagnostics and reports Implementing
Slide 23: Contents
CONTENTS Performance Company Business Model & snapshot Overview Service Portfolio Growth Technology & 06 Financial Strategy Infrastructure Performance Industry Outlook 22
Slide 24: Profit & Loss Statement: Consolidated
PROFIT & LOSS STATEMENT: CONSOLIDATED ₹ crores unless otherwise mentioned Particulars H1 FY26 H1 FY27 YoY Change FY24 FY25 FY26 YoY Change Revenue from operations 45.2 48.9 8% 78.8 83.5 88.5 6% Operating Expense + Cost of Material 16.7 20.5 23% 36.2 31.0 31.0 0% Consumed Employee benefits expense 4.
Slide 25: Balance Sheet: Consolidated
BALANCE SHEET : CONSOLIDATED ₹ crores unless otherwise mentioned Assets FY24 FY25 FY26 H1 FY27 Equity and Liabilities FY24 FY25 FY26 H1 FY27 Share Capital 13.5 13.5 17.4 17.4 Non-current assets Reserves & Surplus 33.7 33.7 98.7 106.5 Property, plant and equipment 20.9 20.9 25.2 28.6 Total shareholde
Slide 26: Cash Flow Statement: Consolidated
CASH FLOW STATEMENT: CONSOLIDATED ₹ crores unless otherwise mentioned Particulars H1 FY27 FY24 FY25 FY26 A Cash Flow from Operating Activities Profit Before Tax 10.7 16.1 21.4 26.3 Add: Non-cash and Non-operating Adj. 3.5 6.4 7.2 7.0 Add/(Less): Working Capital Changes (17.5) (0.4) (25.9) (3.2) Less
Slide 27: Contents
CONTENTS Performance Company Business Model & snapshot Overview Service Portfolio Growth Technology & Financial Strategy Infrastructure Performance 07 Industry Outlook 26
Slide 28: Indian Diagnostics Sector: Growth Drivers and Trends
INDIAN DIAGNOSTICS SECTOR: GROWTH DRIVERS AND TRENDS GROWTH DRIVERS: DIAGNOSTICS INDUSTRY (USD BN) Urbanization, Growing income, expanded test menus, rising non- communicable diseases Market split (2024): Pathology – 56%, Radiology – 44%. FY24E–28P CAGR: 10–12% 570.0 570.0 Chained diagnostics expect
Slide 29: Inclusive Diagnostics: Government-led PPP Strategy
INCLUSIVE DIAGNOSTICS: GOVERNMENT-LED PPP STRATEGY Involves diagnostic Aims to improve Players with strong PPP players maintain players partnering with healthcare access, track records and and operate facilities, the government to offer especially for the competitive pricing ensuring updated patholo
Slide 30: Thank You
THANK YOU For further information, please contact: COMPANY MR. AZAD ALI CFO cs@starimaging.in INVESTOR RELATIONS CONSULTANT Meeting Request Link NeoAtlas Capital Advisory LLP Mr. Pranil Pandya Mr. Rutul Shah pranil@atlascapital.in rutul.shah@atlascapital.in +91 84012 07703 +91 8200247366 29
Star Imaging and Path Lab — H1 FY27 Earnings Presentation on 6ix